FERRARI, SILVIA
 Distribuzione geografica
Continente #
NA - Nord America 1.863
EU - Europa 336
AS - Asia 101
Totale 2.300
Nazione #
US - Stati Uniti d'America 1.863
IT - Italia 201
CN - Cina 53
VN - Vietnam 45
FI - Finlandia 40
SE - Svezia 33
GB - Regno Unito 21
DE - Germania 17
IE - Irlanda 12
FR - Francia 3
NL - Olanda 3
AT - Austria 2
RO - Romania 2
IR - Iran 1
KR - Corea 1
OM - Oman 1
PL - Polonia 1
RU - Federazione Russa 1
Totale 2.300
Città #
Fairfield 375
Ashburn 182
Woodbridge 175
Houston 159
Seattle 147
Cambridge 143
Chandler 121
Wilmington 104
Ann Arbor 100
Padova 52
Dong Ket 45
San Diego 39
Medford 36
Princeton 35
Des Moines 33
Helsinki 27
Roxbury 23
Milan 18
Dublin 12
Beijing 11
Rome 11
Boardman 10
Washington 10
Cagliari 7
London 7
Turin 7
Norwalk 6
Bari 4
Crotone 4
Guardiagrele 4
Hebei 4
Jinan 4
Azzano San Paolo 3
Florence 3
Mainz 3
Nanjing 3
San Severino Marche 3
Sant'Eufemia d'Aspromonte 3
Sesto Fiorentino 3
Shenyang 3
Bolzano 2
Brescia 2
Bucharest 2
Buti 2
Castelbuono 2
Chicago 2
Chiswick 2
Chongqing 2
Correggio 2
Fasano 2
Genoa 2
Hefei 2
Jiaxing 2
Kilburn 2
Loria 2
Lumezzane 2
Mezzano 2
Mezzomerico 2
Modugno 2
New Bedfont 2
New York 2
Orange 2
Paduli 2
Spinea 2
Tianjin 2
Trieste 2
Venezia 2
Venice 2
Avellino 1
Buffalo 1
Changsha 1
Chengdu 1
Foggia 1
Fontenay-sous-bois 1
Groningen 1
Gunzenhausen 1
Kish 1
Kunming 1
Laureana di Borrello 1
Los Angeles 1
Melzo 1
Muggiò 1
Muscat 1
Nanchang 1
Newark 1
Ningbo 1
Ogden 1
Paris 1
Pavia 1
Perugia 1
Pittsburgh 1
Rockville 1
Shaoxing 1
Siena 1
South Gate 1
Southwark 1
Tappahannock 1
Terricciola 1
Udine 1
Warsaw 1
Totale 2.027
Nome #
Aspetti clinici, epidemiologici e genetici delle diverse forme di trombocitopenie ereditarie 187
Activated Platelet-Derived and Leukocyte-Derived Circulating Microparticles and the Risk of Thrombosis in Heparin-Induced Thrombocytopenia: A Role for PF4-Bearing Microparticles? 182
Correlation between ADAMTS13 activity and neurological impairment in acute thrombotic microangiopathy patients 123
A novel germ-line mutation of c-mpl gene in a sporadic case of essential thrombocythemia 115
The Dysprothrombinemias due to Arg596 Mutations: A Conundrum With No Bleeding Tendency and Venous Thrombosis due to Antithrombin Resistance 98
Heterozygous FXII deficiency is not associated with an increased incidence of thrombotic events: Results of a long term study 97
A forgotten or minimized head trauma, rather than a mild FVII deficiency, is the most likely cause of a subdural hematoma 94
Spectrum of 5’UTR mutations in ANKRD26 gene in patients with inherited thrombocytopenia: c.-140C>G mutation is more frequent than expected 93
Thrombotic and Hemorrhagic Conditions Due to a Gain of Function of Coagulation Proteins: A Special Type of Clotting Disorders 85
Vitamin K-Dependent Coagulation Factors That May be Responsible for Both Bleeding and Thrombosis (FII, FVII, and FIX) 81
Thrombotic events in homozygotes with a proven or highly probable Arg304Gln Factor VII mutation (FVII Padua) 1): only limited replacement therapy is needed in case of surgery 78
Thrombotic events in severe FXII deficiency in comparison with unaffected family members during a long observation period 77
A novel RUNX1 mutation with ANKRD26 dysregulation is related to thrombocytopenia in a sporadic form of myelodysplastic syndrome 77
Pathogenetic Role of Factor VII Deficiency and Thrombosis in Cross-Reactive Material Positive Patients 71
The story of serum prothrombin conversion accelerator, proconvertin, stable factor, cothromboplastin, prothrombin accelerator or autoprothrombin I, and their subsequent merging into factor VII 70
Congenital FXI and FVII deficiencies assure an apparent opposite protection against arterial or venous thrombosis: an intriguing observation. 67
Drug-Induced Thrombophilic or Prothrombotic States: An Underestimated Clinical Problem That Involves Both Legal and Illegal Compounds 65
Validation of the ISTH/SSC bleeding assessment tool for inherited platelet disorders: A communication from the Platelet Physiology SSC 65
A family with factor x deficiency from Argentina: a compound heterozygosis due to the combination of a new mutation (Gln138Arg) with an already known one (Glu350Lys) 56
New data on FII, FV, FIX and thrombomodulin defects: blood keeps clotting in normal and in peculiar ways 50
African and African-American Contribution to the Knowledge of the FVII Padua (Arg304Gln) Defect 45
Acquired Isolated FVII Deficiency An Underestimated and Potentially Important Laboratory Finding. 43
Factor X Friuli coagulation disorder: Almost 50 Years Later 40
Prevalence of bleeding manifestations in 128 heterozygotes for Factor X deficiency, mainly for FX Friuli, matched vs 128 unaffected family members, during a long sequential observation period (23.5 years). 39
Bleeding manifestations in heterozygotes with prothrombin deficiency or abnormalities vs. unaffected family members as observed during a long follow-up study 35
A structure–function analysis in patients with prekallikrein deficiency 34
Bleeding manifestations in heterozygotes with congenital FVII deficiency: a comparison with unaffected family members during a long observation period* 34
New clotting disorders that cast new light on blood coagulation and may play a role in clinical practice 34
Congenital prothrombin defects: they are not only associated with bleeding but also with thrombosis: a new classification is needed 33
Heparin, coumarin, protein C, antithrombin, fibrinolysis and other clotting related resistances: old and new concepts in blood coagulation 32
Increased Prevalence of Reported Cases of Congenital Prekallikrein Deficiency Among African Americans as Compared With the General Population of the United States 30
Prothrombin: Another Clotting Factor After FV That Is Involved Both in Bleeding and Thrombosis 29
Role of replacement therapy in the evaluation of thrombosis occurring in congenital bleeding conditions 29
Myocardial Infarctions and Other Acute Coronary Syndromes in Rare Congenital Bleeding Disorders: A Critical Analysis of All Reported Cases. 28
Prevalence of hypertension and its complications in congenital Prekallikrein deficiency: analysis of all reported cases and clinical significance. 26
Cardiovascular diseases in congenital prekallikrein deficiency: Comparison with other chanceassociated morbidities 24
The Lesson Learned from the New c.2547-1G>T Mutation Combined with p.R854Q: When a Type 2N Mutation Reveals a Quantitative von Willebrand Factor Defect 3
Totale 2.369
Categoria #
all - tutte 9.264
article - articoli 8.683
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.947


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201996 0 0 0 0 0 0 0 0 0 0 46 50
2019/2020480 37 43 3 25 47 24 41 58 104 46 43 9
2020/2021509 43 29 35 30 5 9 8 47 106 62 74 61
2021/2022454 3 31 58 3 37 66 16 35 51 23 31 100
2022/2023322 72 18 15 31 60 45 1 11 40 3 21 5
2023/2024279 5 22 59 23 37 50 33 25 10 11 4 0
Totale 2.369